Epicatechin inhibits human plasma lipid peroxidation caused by haloperidol in vitro

Neurochemical Research

Volumn 37, Issue 3, 2012, Pages 557-562

  Dietrich Muszalska, Anna ^a   Kontek, Bogdan ^b   Olas, Beata ^b   Rabe Jabłońska, Jolanta ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

Antipsychotics; Epicatechin; Haloperidol; Lipid peroxidation; Oxidative stress

Indexed keywords

AMISULPRIDE; EPICATECHIN; HALOPERIDOL; RESVERATROL; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ANALYSIS OF VARIANCE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ACTIVITY; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; INCUBATION TIME; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; NITRATIVE STRESS; NORMAL HUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 84862881903     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0642-8     Document Type: Article

References (40)

1. Al-Bloushi S, Safer AM, Afzal M (2009) Mousa SA: green tea modulates reserpine toxicity in animal models. J Toxicol Sci 34:77-87
2. Allebeck P (1989) Schizophrenia: a life-shortening illness. Schizophr Bull 15:81-89
3. Al-Malki AL, Moselhy SS (2010) The protective effect of epicatechin against oxidative stress and nephrotoxicity in rats induced by cyclosporine. Hum Exp Toxicol (in press)
4. Babu PV, Liu D (2008) Green tea catechins and cardiovascular health: an update. Curr Med Chem 15:1840-1850
5. Bergemann N, Kopitz J, Kress KR, Frick A (2004) Plasma amisulpride levels in schizophrenia or schizoaffective disorder. Eur Neuropsychopharmacol 14:245-250 (Pubitemid 38410959)
6. Berstein HG, Bogerts B, Keilhoff G (2005) The many faces of nitric oxide in schizophrenia. A review. Schizoph Res 78:69-86 (Pubitemid 41188326)
7. Dakhale G, Khanzode S, Saoji A, Khobragade L, Turankar A (2004) Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics. Neuropsychobiology 49:205-209 (Pubitemid 38594573)
8. Dietrich-Muszalska A, Kontek B (2010) Lipid peroxidation in patients with schizophrenia. Psychiatry Clin Neurosci 64: 469-475
9. Dietrich-Muszalska A, Olas B, Glowacki R, Bald E (2009) Oxidative/nitrative modifications of plasma proteins and thiols from patients with schizophrenia. Neuropsychobiology 59:1-7
10. Dietrich-Muszalska A, Olas B, Rabe-Jablonska J (2005) Oxidative stress in blood platelets from schizophrenic patients. Platelets 16:386-391 (Pubitemid 41564335)
11. Dietrich-Muszalska A, Olas B (2010) Inhibitory effects of poly-phenol compounds on lipid peroxidation caused by antipsychotics (haloperidol and amisulpride) in human plasma in vitro. World J Biol Psychiatry 11:276-281
12. Dietrich-Muszalska A, Olas B (2007) Isoprostanes as indicators of oxidative stress in schizophrenia. World J Biol Psychiatry 14:1-6
13. Dietrich-Muszalska A, Olas B (2009) Modifications of blood platelet proteins of patients with schizophrenia. Platelets 20: 90-96
14. Dietrich-Muszalska A, Rabe-Jablonska J, Zgirski A (2004) The effects of olanzapine (Zolafren) on lipid peroxidation in human blood platelets and plasma: in vitro studies. Psychiatria i Psychologia Kliniczna 4:13-19
15. Dietrich-Muszalska A (2004) Evaluation of the effects of different concentrations of risperidone, corresponding to the drug doses used in treatment of schizophrenic patients, on lipid per-oxidation in plasma and blood platelets at in vitro studies. Psychiatria i Psychologia Kliniczna 4:215-223
16. Dietrich-Muszalska A (2005) The impact of different concentrations of clozapine on changes of lipid peroxidation in human plasma-in vitro studies. Psychiatria i Psychologia Kliniczna 1:18-25
17. Eerdekens M, van Hove I, Remmerie B, Mannaert E (2004) Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia. Schizophr Res 70:91-100 (Pubitemid 38916632)
18. Fiala ES, Sodum RS, Bhattacharaya M, Li H (1996) (-)-Epigallocatechin gallate, a polyphenolic tea antioxidant, inhibits peroxynitrite-mediated formation of 8-oxodeoxyguanosine and 3-nitrotyrosine. Experientia 52:922-926 (Pubitemid 26326403)
19. Gama CS, Salvador M, Andreazza AC, Kapczinski F, Silva Belmote-De-Abreu P (2006) Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia; a study of patients treated with a haloperidol or clozapine. Prog Neuropsychopharmacol Biol Psychiatry 30:512-515
20. Jeding I, Evans PJ, Akanmu D, Dexter D, Spencer JD, Arunoma OI, Jenner P, Halliwell B (1995) Characterization of the potential antioxidants and pro-oxidant actions of some neuroleptic drugs. Biochem Pharmacol 49:359-365
21. Kropp S, Kern V, Lange K, Degner D, Hajak G, Kornhuber J, Ruther E, Emrich HM, Schneider U, Bleich S (2005) Oxidative stress during treatment with first-and second-generation anti-psychotics. J Neuropsych 17:227-231 (Pubitemid 41350611)
22. Li HC, Chen QZ, Ma Y, Zhou JF (2006) Imbalanced free radicals and antioxidant defense systems in schizophrenia: a comparative study. J Zhejian Univ Sci B 12:981-986
23. Lohr JB, Kuczenski R, Bracha HS, Moir M, Jeste DV (1990) Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia. Biol Psychiatry 28:535-539 (Pubitemid 20298448)
24. Müller MJ, Regenbogen B, Härtter S, Eich FX, Hiemke Ch (2007) Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia. J Psychiatr Res 41: 673-679 (Pubitemid 46498098)
25. Nath RG, Wu MY, Emami A, Chung FL (2010) Effects of epigallocatechin gallate, L-ascorbic acid, alpha-tocopherol, and dihydrolipoic acid on the formation of deoxyguanosine adducts derived from lipid peroxidation. Nutr Cancer 62:622-699
26. Pannala AS, Rice-Evans CA, Halliwell B, Singh S (1997) Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols. Biochem Biophys Res Commun 232:164-168 (Pubitemid 27211940)
27. Parikh V, Khan MM, Mahadik SP (2003) Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J Psychiatr Res 37:43-51 (Pubitemid 35449770)
28. Reddy RD, Yao JK (1996) Free radical pathology in schizophrenia: a review. Prostaglandins Leukot Essent Fatty Acids 55:33-34
29. Sagara Y (1998) Induction of reactive oxygen species in neurons by haloperidol. J Neurochem 71:1002-1012 (Pubitemid 28390254)
30. Scalbert A, Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130:20735-20855
31. Schroeder P, Zhang H, Klotz LO, Kalyanaraman B, Sies H (2001) (-)-Epicatechin inhibits nitration and dimerization of tyrosine in hydrophilic as well as hydrophobic environments. Biochem Biophys Res Commun 289:1334-1338 (Pubitemid 34076339)
32. Seol IW, Kuo NY, Kim KM (2004) Effects of dopaminergic drugs on the mast cell degarulation and nitrix oxide generation in RAW 264.7 cells. Arch Pharm Res 27:94-98 (Pubitemid 43154548)
33. Srivastava N, Barthwal MK, Dalal PK, Agarwal AK, Nag D, Srimal RC, Seth PK, Dikshit M (2001) Nitrite content and antioxidant enzymes levels in the blood of schizophrenic patients. Psychopharmacology 158:140-145 (Pubitemid 33020832)
34. Taylor D, Paton C, Kerwin R (2003) The south London and maudsley NHS trust. Prescribing guidelines, 7th edn. Martin Dunitz, Taylor and Francis Group. London and New York
35. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. IJBCB 39:44084
36. Wachowicz B (1984) Adenine nucleotides in thrombocytes of birds. Cell Biochem Funct 2:167-170
37. Yao JK, Reddy R, Mcelhinny LG, Van Kammen DP (2001) Oxidative damage and schizphrenia: an overview of the evidence and its therapeutic implications. CNS Drugs 15:287-310 (Pubitemid 32337052)
38. Yao JK, Reddy R, Mcelhinny LG, Van Kammen DP (1998) Reduced status of plasma total antioxidant capacity in schizophrenia. Schizoph Res 32:1-8 (Pubitemid 28338118)
39. Young J, Mckinney SB, Ross BM, Wahle KW, Boyle SP (2007) Biomarkers of oxidative stress in schizophrenic and control subjects. Prostaglandins Leukot Essent Fatty Acids 76:73-85 (Pubitemid 46217226)
40. Zhang XY, Tan YL, Cao LY, Wu GY, Xu Q, Shen Y, Zhou DF (2006) Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical anti-psychotics. Schizophr Res 81:291-300 (Pubitemid 43107705)